Feds Greenlight Bulk LSD and THC Maker: Trippy Times Ahead?
Published Date: 3/10/2026
Notice
Summary
Sigma Aldrich Research Biochemicals Inc. wants to become an official bulk maker of some powerful controlled substances, including LSD and THC. People and companies involved with these drugs can share their thoughts or ask for a hearing by May 11, 2026. This move could impact how these substances are produced and regulated, but no direct costs are mentioned yet.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Sigma Aldrich Seeks Bulk-Drug Registration
On December 18, 2025, Sigma Aldrich Research Biochemicals Inc. applied to be registered as a bulk manufacturer for many Schedule I and II controlled substances, including lysergic acid diethylamide (LSD) and tetrahydrocannabinols (THC). The company says it plans to manufacture the listed substances only as reference standards, and interested parties may submit comments or request a hearing on or before May 11, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08595 — Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
The DEA is giving hexahydrocannabinol (HHC) its own official spot on the list of Schedule I drugs, making it clear that HHC is controlled separately from other similar substances. This change starts May 4, 2026, and affects anyone making, selling, or using HHC, which stays illegal under federal law. No new fees or costs are introduced, but the update helps law enforcement and businesses know exactly where HHC stands.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
Previous / Next Documents
Previous: 2026-04654 — Request for Nominations, Hydrographic Services Review Panel
NOAA is looking for new members to join the Hydrographic Services Review Panel, which helps make our oceans safer and smarter for boats and ships. If you’re interested, send your nomination by April 30, 2026. Five spots open starting January 2027, each lasting four years, so it’s a great chance to make waves in marine safety and technology!
Next: 2026-04656 — Japan Smaller Capitalization Fund, Inc. and Nomura Asset Management U.S.A. Inc.
Japan Smaller Capitalization Fund and Nomura Asset Management want to pay out long-term capital gains more often—up to 12 times a year instead of less frequently. This change affects investors in these funds by potentially giving them quicker access to earnings. The SEC is reviewing the request and will decide by March 31, 2026, unless someone asks for a hearing.